These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32370720)

  • 1. Structure-Based Virtual Screening of New Benzoic Acid Derivatives as Trypanosoma cruzi Trans-sialidase Inhibitors.
    Vázquez-Jiménez LK; Paz-González AD; Juárez-Saldivar A; Uhrig ML; Agusti R; Reyes-Arellano A; Nogueda-Torres B; Rivera G
    Med Chem; 2021; 17(7):724-731. PubMed ID: 32370720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzoic Acid Derivatives with Trypanocidal Activity: Enzymatic Analysis and Molecular Docking Studies toward Trans-Sialidase.
    Kashif M; Moreno-Herrera A; Villalobos-Rocha JC; Nogueda-Torres B; Pérez-Villanueva J; Rodríguez-Villar K; Medina-Franco JL; de Andrade P; Carvalho I; Rivera G
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29084172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, molecular docking and biological evaluation of novel phthaloyl derivatives of 3-amino-3-aryl propionic acids as inhibitors of Trypanosoma cruzi trans-sialidase.
    Kashif M; Chacón-Vargas KF; López-Cedillo JC; Nogueda-Torres B; Paz-González AD; Ramírez-Moreno E; Agusti R; Uhrig ML; Reyes-Arellano A; Peralta-Cruz J; Ashfaq M; Rivera G
    Eur J Med Chem; 2018 Aug; 156():252-268. PubMed ID: 30006170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments in trans-sialidase inhibitors of Trypanosoma cruzi.
    Kashif M; Moreno-Herrera A; Lara-Ramirez EE; Ramírez-Moreno E; Bocanegra-García V; Ashfaq M; Rivera G
    J Drug Target; 2017 Jul; 25(6):485-498. PubMed ID: 28140698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis and kinetic evaluation of aryl α-aminophosphonates as novel inhibitors of T. cruzi trans-sialidase.
    Chen Z; Marcé P; Resende R; Alzari PM; Frasch AC; van den Elsen JMH; Crennell SJ; Watts AG
    Eur J Med Chem; 2018 Oct; 158():25-33. PubMed ID: 30199703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase.
    Neres J; Bonnet P; Edwards PN; Kotian PL; Buschiazzo A; Alzari PM; Bryce RA; Douglas KT
    Bioorg Med Chem; 2007 Mar; 15(5):2106-19. PubMed ID: 17218104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
    Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
    Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion.
    Marchiori MF; Riul TB; Oliveira Bortot L; Andrade P; Junqueira GG; Foca G; Doti N; Ruvo M; Dias-Baruffi M; Carvalho I; Campo VL
    Bioorg Med Chem; 2017 Nov; 25(21):6049-6059. PubMed ID: 29032929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
    Miller BR; Roitberg AE
    Future Med Chem; 2013 Oct; 5(15):1889-900. PubMed ID: 24144418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and enzymatic evaluation of 3-O-substituted aryl β-D-galactopyranosides as inhibitors of Trypanosoma cruzi trans-sialidase.
    Silva BL; S Filho JD; Andrade P; Carvalho I; Alves RJ
    Bioorg Med Chem Lett; 2014 Sep; 24(18):4529-4532. PubMed ID: 25149510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
    Neres J; Bryce RA; Douglas KT
    Drug Discov Today; 2008 Feb; 13(3-4):110-7. PubMed ID: 18275908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor substrate binding to trans-sialidase of Trypanosoma cruzi as studied by STD NMR.
    Blume A; Neubacher B; Thiem J; Peters T
    Carbohydr Res; 2007 Sep; 342(12-13):1904-9. PubMed ID: 17597593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro and in vivo evaluation of new potential trans-sialidase inhibitors of Trypanosoma cruzi predicted by a computational drug repositioning method.
    Lara-Ramirez EE; López-Cedillo JC; Nogueda-Torres B; Kashif M; Garcia-Perez C; Bocanegra-Garcia V; Agusti R; Uhrig ML; Rivera G
    Eur J Med Chem; 2017 May; 132():249-261. PubMed ID: 28364659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 4-amino-3-nitrobenzoic acid on the expression level of the trans-sialidase gene in Trypanosoma cruzi epimastigotes.
    Vázquez-Jiménez LK; Paz-González AD; Kashif M; Juárez-Rendón KJ; Nogueda-Torres B; Bocanegra-García V; Rivera G
    Pak J Pharm Sci; 2019 Mar; 32(2 (Supplementary)):825-829. PubMed ID: 31103978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase.
    Amaya MF; Buschiazzo A; Nguyen T; Alzari PM
    J Mol Biol; 2003 Jan; 325(4):773-84. PubMed ID: 12507479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Virtual Screening and In Vitro Evaluation of New
    Herrera-Mayorga V; Lara-Ramírez EE; Chacón-Vargas KF; Aguirre-Alvarado C; Rodríguez-Páez L; Alcántara-Farfán V; Cordero-Martínez J; Nogueda-Torres B; Reyes-Espinosa F; Bocanegra-García V; Rivera G
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of PEGylated lactose analogs for inhibition studies on T.cruzi trans-sialidase.
    Giorgi ME; Ratier L; Agusti R; Frasch AC; de Lederkremer RM
    Glycoconj J; 2010 Jul; 27(5):549-59. PubMed ID: 20645127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of e-pharmacophore models using compound fragments for the trans-sialidase of Trypanosoma cruzi: screening for novel inhibitor scaffolds.
    Miller BR; Roitberg AE
    J Mol Graph Model; 2013 Sep; 45():84-97. PubMed ID: 24012872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of new and selective Trypanosoma cruzi trans-sialidase inhibitors from sulfonamide chalcones and their derivatives.
    Kim JH; Ryu HW; Shim JH; Park KH; Withers SG
    Chembiochem; 2009 Oct; 10(15):2475-9. PubMed ID: 19780074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new class of mechanism-based inhibitors for Trypanosoma cruzi trans-sialidase and their influence on parasite virulence.
    Carvalho ST; Sola-Penna M; Oliveira IA; Pita S; Gonçalves AS; Neves BC; Sousa FR; Freire-de-Lima L; Kurogochi M; Hinou H; Nishimura S; Mendonça-Previato L; Previato JO; Todeschini AR
    Glycobiology; 2010 Aug; 20(8):1034-45. PubMed ID: 20466651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.